Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 24.95
-0.09 (-0.36%)
May 22, 2026, 3:27 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.38 billion as of May 22, 2026. Its market cap has decreased by -49.64% in one year.
Market Cap
1.38B
Enterprise Value
1.56B
Revenue
2.76B
Ranking
n/a
PE Ratio
14.36
Stock Price
24.95
Market Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.38B, an increase of 3,234.06%. That is a compound annual growth rate of 39.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.38B | -6.74% |
| Dec 31, 2025 | 1.48B | -59.70% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.43B |
| Sigachi Industries | 7.78B |
| Valiant Laboratories | 4.18B |
| Bafna Pharmaceuticals | 3.19B |
| Nectar Lifesciences | 2.37B |
| Brooks Laboratories | 1.58B |
| Alpa Laboratories | 1.46B |
| Par Drugs and Chemicals | 1.06B |